Literature DB >> 16142734

Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus.

Hirofumi Amano1, Eri Amano, Marie-Laure Santiago-Raber, Thomas Moll, Eduardo Martinez-Soria, Liliane Fossati-Jimack, Masahiro Iwamoto, Stephen J Rozzo, Brian L Kotzin, Shozo Izui.   

Abstract

OBJECTIVE: Monocytosis is a unique cellular abnormality associated with the Yaa (Y-linked autoimmune acceleration) mutation. The present study was designed to define the cellular mechanism responsible for the development of monocytosis and to characterize the effect of the Yaa mutation on the development of monocyte subsets.
METHODS: We produced bone marrow chimeras reconstituted with a mixture of Yaa and non-Yaa bone marrow cells bearing distinct Ly-17 alloantigens, and determined whether monocytes of Yaa origin became dominant. Moreover, we defined the 2 major inflammatory (Gr-1+,CD62 ligand [CD62L]+) and resident (Gr-1-,CD62L-) subsets of blood monocytes in aged BXSB Yaa male mice, as compared with BXSB male mice lacking the Yaa mutation.
RESULTS: Analysis of the Ly17 allotype of blood monocytes in chimeric mice revealed that monocytes of both Yaa and non-Yaa origin were similarly involved in monocytosis. Significantly, the development of monocytosis paralleled a selective expansion of the resident monocyte subset compared with the inflammatory subset, and the former expressed CD11c, a marker of dendritic cells. Neither monocytosis nor the change in monocyte subpopulations, including CD11c expression, was observed in Yaa-bearing C57BL/6 mice, in which systemic lupus erythematosus (SLE) fails to develop.
CONCLUSION: Our results suggest that Yaa-associated monocytosis is not attributable to an intrinsic abnormality in the growth potential of monocyte lineage cells bearing the Yaa mutation and that the Yaa mutation could lead to the expansion of dendritic cells, thereby contributing to the accelerated development of SLE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142734     DOI: 10.1002/art.21365

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  Distinct roles of CSF-1 isoforms in lupus nephritis.

Authors:  Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; E Richard Stanley; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

Review 2.  Elucidation of monocyte/macrophage dynamics and function by intravital imaging.

Authors:  Rejane Rua; Dorian B McGavern
Journal:  J Leukoc Biol       Date:  2015-07-10       Impact factor: 4.962

3.  CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation.

Authors:  Beat A Imhof; Stephane Jemelin; Romain Ballet; Christian Vesin; Marc Schapira; Melis Karaca; Yalin Emre
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

4.  A Tlr7 translocation accelerates systemic autoimmunity in murine lupus.

Authors:  Srividya Subramanian; Katalin Tus; Quan-Zhen Li; Andrew Wang; Xiang-Hong Tian; Jinchun Zhou; Chaoying Liang; Guy Bartov; Lisa D McDaniel; Xin J Zhou; Roger A Schultz; Edward K Wakeland
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-15       Impact factor: 11.205

5.  B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.

Authors:  Chi G Weindel; Lauren J Richey; Silvia Bolland; Abhiruchi J Mehta; John F Kearney; Brigitte T Huber
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.

Authors:  Ngoc Lan Tran; Céline Manzin-Lorenzi; Marie-Laure Santiago-Raber
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

7.  Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Authors:  YuFeng Peng; Yvette Latchman; Keith B Elkon
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation.

Authors:  Jonathan A Deane; Prapaporn Pisitkun; Rebecca S Barrett; Lionel Feigenbaum; Terrence Town; Jerrold M Ward; Richard A Flavell; Silvia Bolland
Journal:  Immunity       Date:  2007-11-08       Impact factor: 31.745

9.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

10.  Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Robert D Schreiber; Brian R Lawson; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Immunol       Date:  2012-11-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.